Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07513207
PHASE1

A Study in Healthy People to Test How Vicadrostat Affects the Heart

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

The main objective of this trial is to investigate the effect of vicadrostat on the heart compared with placebo in healthy male and female volunteers.

Official title: Thorough QT Study to Evaluate the Effects of Single Doses of Vicadrostat on Cardiac Safety Parameters in Healthy Male and Female Subjects (a Randomized, Placebo-controlled, Double-blind, Five-period Crossover Study With Open-label Moxifloxacin as Positive Control)

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2026-04-22

Completion Date

2026-08-21

Last Updated

2026-04-07

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Vicadrostat

Vicadrostat

DRUG

Placebo matching Vicadrostat

Placebo matching Vicadrostat

DRUG

Moxifloxacin

Moxifloxacin

Locations (1)

Humanpharmakologisches Zentrum Biberach

Biberach, Germany